Patents by Inventor Martin Decaris

Martin Decaris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOSAGE FORMS AND REGIMENS FOR AMINO ACID COMPOUNDS
    Publication number: 20230117605
    Abstract: The invention relates to dosage forms for daily administration of compounds of formula (A) and formula (I): or a salt thereof, wherein R1, R2, R10, R11, R12, R13, R14, R15, R16, q and p are as described herein. Compounds of formula (A), formula (I), and pharmaceutical compositions thereof are ?v?6 integrin inhibitors that are useful for treating fibrosis such as idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP).
    Type: Application
    Filed: July 20, 2022
    Publication date: April 20, 2023
    Inventors: Martin DECARIS, Scott TURNER, Eric LEFEBVRE
  • EXPANDED DOSAGE REGIMENS FOR INTEGRIN INHIBITORS
    Publication number: 20230028658
    Abstract: The invention relates to dosage forms for daily administration of compounds of formula (A) and formula (I): or a salt thereof, wherein R1, R2, R10, R11, R12, R13, R14, R15, R16, q and p are as described herein. Compounds of formula (A), formula (I), and pharmaceutical compositions thereof are ?v?6 integrin inhibitors that are useful for treating fibrosis such as idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP).
    Type: Application
    Filed: April 29, 2022
    Publication date: January 26, 2023
    Inventors: Scott TURNER, Eric LEFEBVRE, Martin DECARIS
  • Dosage forms and regimens for amino acid compounds
    Patent number: 11419869
    Abstract: The invention relates to dosage forms for daily administration of compounds of formula (A) and formula (I): or a salt thereof, wherein R1, R2, R10, R11, R12, R13, R14, R15, R16, q and p are as described herein. Compounds of formula (A), formula (I), and pharmaceutical compositions thereof are ?v?6 integrin inhibitors that are useful for treating fibrosis such as idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP).
    Type: Grant
    Filed: April 8, 2020
    Date of Patent: August 23, 2022
    Assignee: Pliant Therapeutics, Inc.
    Inventors: Martin Decaris, Scott Turner, Eric Lefebvre
  • DOSAGE FORMS AND REGIMENS FOR AMINO ACID COMPOUNDS
    Publication number: 20200352942
    Abstract: The invention relates to dosage forms for daily administration of compounds of formula (A) and formula (I): or a salt thereof, wherein R1, R2, R10, R11, R12, R13, R14, R15, R16, q and p are as described herein. Compounds of formula (A), formula (I), and pharmaceutical compositions thereof are ?v?6 integrin inhibitors that are useful for treating fibrosis such as idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP).
    Type: Application
    Filed: April 8, 2020
    Publication date: November 12, 2020
    Inventors: Jacob CHA, Chengguo DONG, Timothy HOM, Lan JIANG, Katerina LEFTHERIS, Hui LI, David J. MORGANS, JR., Manuel MUNOZ, Maureen REILLY, Yajun ZHENG, Martin DECARIS, Scott TURNER
  • Decellularized extracellular matrix
    Patent number: 9623051
    Abstract: Methods for producing compositions of decellularized extracellular matrix (DM) tissue culture are described. The compositions can be used for coating supports such as tissue culture substrates, osteogenic gels, and medical devices.
    Type: Grant
    Filed: April 16, 2012
    Date of Patent: April 18, 2017
    Assignee: The Regents of the University of California
    Inventors: J. Kent Leach, Martin Decaris, Archana Bhat
  • Method for replacing biomarkers of protein kinetics from tissue samples by biomarkers of protein kinetics from body fluids after isotopic labeling in vivo
    Patent number: 9134319
    Abstract: Provided herein are method for measuring the rate of synthesis, breakdown, transport, or other kinetic parameters of a protein in a tissue of medical interest, without requiring physical sampling of the tissue, by a measurement of the protein in a body fluid.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: September 15, 2015
    Assignees: The Regents of the University of California, KineMed, Inc.
    Inventors: Marc K. Hellerstein, Martin Decaris, Mahalakshmi Shankaran
  • Decellularized Extracellular Matrix
    Publication number: 20140023723
    Abstract: Methods for producing compositions of decellularized extracellular matrix (DM) tissue culture are described. The compositions can be used for coating supports such as tissue culture substrates, osteogenic gels, and medical devices.
    Type: Application
    Filed: April 16, 2012
    Publication date: January 23, 2014
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: J. Kent Leach, Martin Decaris, Archana Bhat